1. Document de presse | 2023.03.15

    Emergence of extensively drug-resistant Shigella sonnei strain in France

    Shigellosis, a highly contagious diarrheal disease, is caused by Shigella bacteria circulating in industrializing countries but also in industrialized countries. Scientists from the French National Reference Center for Escherichia coli, Shigella and Salmonella at the Institut Pasteur who have been monitoring Shigella in France for several years have detected the emergence of extensively drug-...

  2. News | 2014.06.30

    The Institut Pasteur signs Memorandum of Understanding with the Institut of Liver and Biliary Sciences in India

    The Institut Pasteur, the Institute of Liver & Biliary Sciences (ILBS) and the Government of National Capital Territory (NCT) of Delhi have signed a memorandum of understanding (MOU) which aims to promote the implementation and execution of collaborative research projects and organize joint scientific shops at bilateral or multilateral level. Exchange of scientists, PhD and MDPhD will be...

  3. Article | 2020.10.02

    TECHNOLOGY TRANSFER AND INDUSTRIAL PARTNERSHIP

     Isabelle Buckle,Executive VPDr. Buckle, PhD, joined the Institut Pasteur in 2014 as Executive Vice-President for Technology Transfer and Industrial Partnership. Isabelle Buckle arrived armed with almost 30 years of scientific, commercial and business skills in Biotechnology forged from previous experiences at Bruker Daltonics as Global Vice President Clinical Mass Spectrometry (CEO and...

  4. Article | 2016.12.21

    Dedonder Clayton Award

    The Dedonder Clayton Award honors scientists in Africa and Asia whose outstanding research is decisive to progress in public health, specifically in the field of research on HIV / AIDS and related infections.

  5. News | 2022.02.28

    Signing of an exclusive license agreement between the Institut Pasteur and Meletios Therapeutics for the development of a new class of antivirals

    The exclusive worldwide license agreement signed between the Institut Pasteur and Meletios Therapeutics, a French biotechnology company specializing in the research and development of next-generation antiviral therapies, concerned a technology platform for the generation of Defective Viral Genomes (DVG). DVGs are truncated or rearranged copies of a virus, making these viral sequences non-...

  6. Article | 2016.12.20

    University of Coimbra Medical school PT

    This program allows students from the University of Coimbra to spend up to 6 months in a laboratory at Institut Pasteur. Applicants are selected through a competitive call, based on the analysis of the CV. In order to maximize their motivation selected trainees are allowed to choose their host centre.

  7. Article | 2017.01.16

    Previous and current students

    Students selected within the PPU program come from all continents and their educational backgrounds and diplomas are often various, which participates to the richness of this multidisciplinary program. Each class receives a name corresponding to a renowned scientist who had worked at the Institut Pasteur.

  8. Article | 2019.02.22

    PPU-Oxford Program

    "Chimie Biologique"Linking Chemistry and Microbiology to Fight Human Diseases

  9. Document de presse | 2025.03.17

    Hepatitis B: new rapid diagnostic test to halt mother-to-child transmission

    Scientists from the Institut Pasteur, in collaboration with Kumamoto University in Japan, have assessed a new rapid diagnostic test to identify pregnant women at elevated risk of transmitting hepatitis B to their babies. This diagnostic tool could help eliminate hepatitis B by preventing mother-to-child transmission during childbirth, especially in low- and middle-income countries. Hepatitis B is...

  10. Document de presse | 2020.06.23

    COVID-19 in primary schools: no significant transmission among children or from students to teachers

    In late April 2020, scientists at the Institut Pasteur, with the support of the Hauts-de-France Regional Health Agency and the Amiens Education Authority, carried out an epidemiological survey on 1,340 people linked to primary schools in Crépy-en-Valois, in the Oise department. Thanks to the cooperation of the people of Crépy-en-Valois, the survey, which made use of serological tests developed by...

Pages

Back to top